Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
Novel immune-related susceptibility loci associated with pediatric steroid-sensitive nephrotic syndrome identified by a transethnic genome-wide association study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Xueying, Tian Zijian, Chen Xueting, Shao Jian, Wang Li, Ni Fenfen, Liang Rui, Zhao Bo, Feng Shipin, Gao Xiaojie, Cui Jingjing, Yang Xia, Chen Xuelan, Li Xiaoqin, Yang Baohui, Wan Junli, Jiao Jia, Wang Anshuo, Yang Qin, Yang Xuejun, Wu Daoqi, Zhang Gaofu, Wang Mo, Zhou Kaixin, Chan Han, Yang Haiping, Li Qiu
Аннотация
BACKGROUND: Steroid-sensitive nephrotic syndrome (SSNS) is a relatively rare glomerular disease with considerable clinical and genetic heterogeneity. Although efforts have been made to explore the genetic determinants of SSNS, the underlying genetic architecture has still been hampered by limited sample size and remains to be elucidated.
METHODS: We conducted a genome-wide association study involving 510 sporadic pediatrics of SSNS and 1062 controls with Chinese ancestry, followed by a transethnic meta-analysis involving 2942 cases and 37 041 controls. We evaluated the colocalization probability between single-cell expression quantitative trait loci, plasma protein quantitative trait loci, and the novel loci using the colocalization method. We explored the potential causal effects using Mendelian randomization (MR) and assessed the clinical associations of polygenic risk scores (PRS) for SSNS.
RESULTS: Two novel genome-wide significant signals, rs4309200 from M6PR-KLRG1 (P = 4.70 × 10-9, OR = 1.23, 95%CI = 1.16-1.30) and rs9303279 from GSDMB-ORMDL3 (P = 7.25 × 10-9, OR = 0.82, 95%CI = 0.75-0.89), both highly related to immunological function, were identified for SSNS. Colocalization and MR analyses revealed that a genetic tendency toward higher M6PR expression in NK and CD4+ T cells with an effector memory or central memory phenotype (CD4 ET) was associated with an increased risk of SSNS (NK: PPH4 = 0.93; P = 2.04 × 10-4, OR = 1.60; CD4 ET: PPH4 = 0.91; P = 8.14 × 10-3, OR = 2.28), whereas higher ORMDL3 expression in B memory and CD4 ET cells was associated with a lower risk of SSNS (B memory: PPH4 = 0.93; P = 3.83 × 10-8, OR = 0.61; CD4 ET: PPH4 = 0/92; P = 1.82 × 10-9, OR = 0.49). The clinical correlation analysis confirmed that a higher PRS is associated with an earlier age of onset, and the rs56117924 from the NPHS1 gene may predominantly drive this association.
CONCLUSION: We identified two novel immune-related loci associated with susceptibility to SSNS, nominating M6PR and ORMDL3 as potential contributors to SSNS risk in a cell-type-specific manner, and confirmed the association of PRS with earlier disease onset. These findings expand our knowledge of the genetic architecture of SSNS and highlight the importance of large-scale collaborations in uncovering genetic associations related to SSNS.
METHODS: We conducted a genome-wide association study involving 510 sporadic pediatrics of SSNS and 1062 controls with Chinese ancestry, followed by a transethnic meta-analysis involving 2942 cases and 37 041 controls. We evaluated the colocalization probability between single-cell expression quantitative trait loci, plasma protein quantitative trait loci, and the novel loci using the colocalization method. We explored the potential causal effects using Mendelian randomization (MR) and assessed the clinical associations of polygenic risk scores (PRS) for SSNS.
RESULTS: Two novel genome-wide significant signals, rs4309200 from M6PR-KLRG1 (P = 4.70 × 10-9, OR = 1.23, 95%CI = 1.16-1.30) and rs9303279 from GSDMB-ORMDL3 (P = 7.25 × 10-9, OR = 0.82, 95%CI = 0.75-0.89), both highly related to immunological function, were identified for SSNS. Colocalization and MR analyses revealed that a genetic tendency toward higher M6PR expression in NK and CD4+ T cells with an effector memory or central memory phenotype (CD4 ET) was associated with an increased risk of SSNS (NK: PPH4 = 0.93; P = 2.04 × 10-4, OR = 1.60; CD4 ET: PPH4 = 0.91; P = 8.14 × 10-3, OR = 2.28), whereas higher ORMDL3 expression in B memory and CD4 ET cells was associated with a lower risk of SSNS (B memory: PPH4 = 0.93; P = 3.83 × 10-8, OR = 0.61; CD4 ET: PPH4 = 0/92; P = 1.82 × 10-9, OR = 0.49). The clinical correlation analysis confirmed that a higher PRS is associated with an earlier age of onset, and the rs56117924 from the NPHS1 gene may predominantly drive this association.
CONCLUSION: We identified two novel immune-related loci associated with susceptibility to SSNS, nominating M6PR and ORMDL3 as potential contributors to SSNS risk in a cell-type-specific manner, and confirmed the association of PRS with earlier disease onset. These findings expand our knowledge of the genetic architecture of SSNS and highlight the importance of large-scale collaborations in uncovering genetic associations related to SSNS.